Achaogen, Inc. (AKAO)
AKAO Price and Sentiment
AKAO Latest news
Achaogen (AKAO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nanocap biotech Achaogen Inc (NASDAQ: AKAO) has been pushed to the brink, with the company announcing Monday that it has voluntarily filed for Chapter 11 bankruptcy.
Achaogen (AKAO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors need to pay close attention to Achaogen (AKAO) stock based on the movements in the options market lately.
Achaogen, Inc. (AKAO) CEO Blake Wise on Q4 2018 Results - Earnings Call Transcript